In 2023, the mortality rate of liver malignant neoplasms in the US was reported at a certain benchmark, which served as the latest point of reference. For the forecasted period from 2024 to 2028, the mortality rate shows a slight annual increase, with 2024 starting at 9.1 deaths per hundred thousand persons and gradually rising to 9.7 by 2028. The year-on-year variation reveals a trend of stable growth in mortality rates, averaging approximately 1.35% annual increase over the five-year span.
Future trends to watch for include advancements in early detection and treatment methodologies, public health initiatives aimed at reducing risk factors such as alcohol consumption and hepatitis infection, and potential demographic shifts impacting the prevalence of liver cancer. These factors could influence the forecasted mortality rate trends over the long term.
